Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bucher

Showing results (351-360 of 406) with videos related to

Pageof 41
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|October 15, 2019
Effectiveness of Transmitted Drug Resistance Testing Before Initiation of Antiretroviral Therapy in HIV-Positive IndividualsSara Lodi, Huldrych F Günthard, John Gill, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 13, 2023
Measures of Longitudinal Immune Dysfunction and Risk of AIDS and Non-AIDS Defining Malignancies in Antiretroviral-Treated People With Human Immunodeficiency VirusFrédérique Chammartin, Amanda Mocroft, Alexander Egle, et al.
Trials|October 22, 2021
A trial platform to assess approved SARS-CoV-2 vaccines in immunocompromised patients: first sub-protocol for a pilot trial comparing the mRNA vaccines Comirnaty® and COVID-19 mRNA Vaccine Moderna®Benjamin Speich, Frédérique Chammartin, Daniel Smith, et al.
Clinical Chemistry and Laboratory Medicine|January 13, 2015
Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a US health system perspectivePhilipp Schuetz, Robert Balk, Matthias Briel, et al.
Neurology|June 8, 2014
Antiretroviral penetration into the CNS and incidence of AIDS-defining neurologic conditionsEllen C Caniglia, Lauren E Cain, Amy Justice, et al.
Annals of Internal Medicine|April 20, 2011
When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study, Lauren E Cain, Roger Logan, et al.
AIDS (London, England)|November 15, 2017
Effect of immediate initiation of antiretroviral treatment on the risk of acquired HIV drug resistanceSara Lodi, Huldrych F Günthard, David Dunn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 31, 2012
Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countriesJulia del Amo, Santiago Moreno, Heiner C Bucher, et al.
BMJ (Clinical Research Ed.)|February 18, 2009
Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysisMatthias Briel, Ignacio Ferreira-Gonzalez, John J You, et al.
Plos One|January 24, 2025
Low agreement and frequent invalid controls in two SARS-CoV-2 T-cell assays in people with compromised immune functionAnnette Audigé, Alain Amstutz, Macé M Schuurmans, et al.
Pageof 41

Showing results (351-360 of 406) with videos related to

Sort By:
Pageof 41
Journal of Acquired Immune Deficiency Syndromes (1999)|October 15, 2019
Effectiveness of Transmitted Drug Resistance Testing Before Initiation of Antiretroviral Therapy in HIV-Positive IndividualsSara Lodi, Huldrych F Günthard, John Gill, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 13, 2023
Measures of Longitudinal Immune Dysfunction and Risk of AIDS and Non-AIDS Defining Malignancies in Antiretroviral-Treated People With Human Immunodeficiency VirusFrédérique Chammartin, Amanda Mocroft, Alexander Egle, et al.
Trials|October 22, 2021
A trial platform to assess approved SARS-CoV-2 vaccines in immunocompromised patients: first sub-protocol for a pilot trial comparing the mRNA vaccines Comirnaty® and COVID-19 mRNA Vaccine Moderna®Benjamin Speich, Frédérique Chammartin, Daniel Smith, et al.
Clinical Chemistry and Laboratory Medicine|January 13, 2015
Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a US health system perspectivePhilipp Schuetz, Robert Balk, Matthias Briel, et al.
Neurology|June 8, 2014
Antiretroviral penetration into the CNS and incidence of AIDS-defining neurologic conditionsEllen C Caniglia, Lauren E Cain, Amy Justice, et al.
Annals of Internal Medicine|April 20, 2011
When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study, Lauren E Cain, Roger Logan, et al.
AIDS (London, England)|November 15, 2017
Effect of immediate initiation of antiretroviral treatment on the risk of acquired HIV drug resistanceSara Lodi, Huldrych F Günthard, David Dunn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 31, 2012
Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countriesJulia del Amo, Santiago Moreno, Heiner C Bucher, et al.
BMJ (Clinical Research Ed.)|February 18, 2009
Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysisMatthias Briel, Ignacio Ferreira-Gonzalez, John J You, et al.
Plos One|January 24, 2025
Low agreement and frequent invalid controls in two SARS-CoV-2 T-cell assays in people with compromised immune functionAnnette Audigé, Alain Amstutz, Macé M Schuurmans, et al.
Pageof 41